NCT01828827View on ClinicalTrials.gov

Food Effect Study on the Bioavailability and PK of PA-824 Tablets in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions
Tuberculosis
Interventions
DRUG

PA-824 1000 mg

Two single administrations of 1000mg each administered by 5 tablets of 200mg, one administered in the fed state and one administered in the fasted state.

Trial Locations (1)

68502

MDS Pharma Services, Lincoln

All Listed Sponsors
lead

Global Alliance for TB Drug Development

OTHER

NCT01828827 - Food Effect Study on the Bioavailability and PK of PA-824 Tablets in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter